The Use of LMA-Proseal and Endobronchial Blocker for One Lung Anesthesia, Case Series

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

29 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-04-30

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An observational pilot study to determine the success rate of using LMA Proseal in conjuction with endobronchial blocker to provide one-lung anesthesia for thoracic surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Supreme LMA and Proseal LMA in Prone Anesthetized Patient

NCT01814306

Inadequate or Impaired Breathing Pattern or Ventilation

UNKNOWN NA

Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

NCT01035021

General Anesthesia Breast Disease

COMPLETED NA

Evaluating Optimal Operating Table Height for ProSeal-LMA™ Insertion

NCT04338412

Evaluation of Optimal Operating Table Height for Successful Placement of Proseal Laryngeal Mask Airway

UNKNOWN NA

Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway Insertion Decreasing Propofol in Elderly

NCT05310110

Anesthesia, General

COMPLETED NA

Comparing the Clinical Performance of BlockBuster vs Proseal-LMA in Unparalysed Patients Undergoing General Anesthesia

NCT06058481

Supraglottic Airway Device

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The use of LMA has gained popularity secondary to benefits confirmed by many literatures. However, LMA is rarely used in thoracic surgery. To enable one-lung ventilation, the LMA need to be used with bronchial blocker. The use of this combination has been reported as a rescue technique in special clinical scenarios, i.e. patient with difficult airway. When used in patient with difficult airway, the LMA will be inserted until proper ventilation achieved, then endobronchial blocker will be subsequently placed through the LMA into the selected main bronchus. The success rate of the the bronchial blocker placement via properly placed LMA has never been studied. This pilot study was designed to evaluate the success rate, the quality of lung collapsed, the dislodgement or other associated problems including some minor complications i.e. postoperative dysphagia, sore throat hoarseness of voice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthetic Technique One-lung Ventilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bronchial blocker

Pilot study to enroll ASA class I-III patients age between 18-70 years who undergoes thoracic surgery which require one-lung ventilation.

Bronchial blocker (Coopdech, Arndt)

Intervention Type DEVICE

Using bronchial blocker with LMA

LMA-ProsealTM

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bronchial blocker (Coopdech, Arndt)

Using bronchial blocker with LMA

Intervention Type DEVICE

LMA-ProsealTM

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Coopdech Arndt

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* Restrictive lung disease that needed positive pressure ventilation \> 30 cm.H2O
* Mass or hematoma in the mouth which obstruct LMA insertion
* Emergency surgery
* Pregnancy
* Severe infection or active pulmaonary tuberculosis
* Hemoptysis
* Pulmonary nodule \> 20 cm. or bronchilal pathology
* Pneumonectomy or sleeve resection

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No